CES is not just any event; it is the place where innovators, entrepreneurs, and future technologies come together. For us, CES offers the ideal stage to show how we are changing the screening for eye disease and beyond!
CES is a great place to forster networks and partnerships. Research and development of next generation products is a vital part of the RetinaScope activities. Relevant and valuable health solutions can only be created in partnership with patients, care and cure providers, prevention projects, insurers and government.
RetinaScope is ready to accellerate and scale and is looking for long term relationships with investors in the US and worldwide to go on a mission to prevent vision loss!
RetinaScope BV was established in 2018 as a spin-out of the Dutch Value Added Distribution company IDCP BV by its founder, Jan Boers. In early 2020, TNO became a shareholder, and the Innovation Fund North Holland provided a convertible loan.